SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-018048
Filing Date
2016-05-05
Accepted
2016-05-05 17:26:52
Documents
76
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rptp-10q_20160331.htm 10-Q 1701805
2 EX-31.1 rptp-ex311_8.htm EX-31.1 8859
3 EX-31.2 rptp-ex312_7.htm EX-31.2 8956
4 EX-32.1 rptp-ex321_6.htm EX-32.1 8889
  Complete submission text file 0001564590-16-018048.txt   7127600

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rptp-20160331.xml EX-101.INS 1577970
6 XBRL TAXONOMY EXTENSION SCHEMA rptp-20160331.xsd EX-101.SCH 59202
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rptp-20160331_cal.xml EX-101.CAL 56417
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rptp-20160331_def.xml EX-101.DEF 176348
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptp-20160331_lab.xml EX-101.LAB 425243
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptp-20160331_pre.xml EX-101.PRE 333962
Mailing Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949
Business Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949 415-408-6200
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25571 | Film No.: 161625130
SIC: 2834 Pharmaceutical Preparations